Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Invested Capital (2020 - 2025)

Historic Invested Capital for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to -$15.8 million.

  • Celularity's Invested Capital fell 19149.31% to -$15.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.8 million, marking a year-over-year decrease of 19149.31%. This contributed to the annual value of $12.7 million for FY2024, which is 7911.42% down from last year.
  • Celularity's Invested Capital amounted to -$15.8 million in Q3 2025, which was down 19149.31% from -$21.2 million recorded in Q2 2025.
  • Celularity's Invested Capital's 5-year high stood at $236.5 million during Q4 2022, with a 5-year trough of -$47.4 million in Q2 2021.
  • For the 5-year period, Celularity's Invested Capital averaged around $65.3 million, with its median value being $44.3 million (2023).
  • Over the last 5 years, Celularity's Invested Capital had its largest YoY gain of 182431.85% in 2021, and its largest YoY loss of 104809.08% in 2021.
  • Over the past 5 years, Celularity's Invested Capital (Quarter) stood at $99.4 million in 2021, then soared by 137.89% to $236.5 million in 2022, then tumbled by 74.26% to $60.9 million in 2023, then plummeted by 79.11% to $12.7 million in 2024, then crashed by 224.36% to -$15.8 million in 2025.
  • Its Invested Capital was -$15.8 million in Q3 2025, compared to -$21.2 million in Q2 2025 and -$1.3 million in Q1 2025.